44 reports

Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders - Overview

179 pages • By CHI Insight Pharma Reports

Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders has a focus in biomarkers for neurodegenerative diseases and diagnostic applications in development. Biomarkers have been a heavily studied topic of interest, and recently on the rise is the interest in neurodegenerative disorders. Although there...

1 996 2 495 1 597
Jul 2014

Biomarkers in Alzheimers Disease

95 pages • By CHI Insight Pharma Reports

OverviewBiomarkers in Alzheimer’s Disease is focused on the biomarker identification and development in patients with Alzheimer’s Disease. As a spin-off of Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders, this report focuses on the Alzheimer’s Disease space featured in the parent report,...

559 699 447
Jul 2014

Analysis of the Western European Biomarkers Market in Drug Discovery and Development

153 pages • By Frost & Sullivan

Increasing Applications of Biomarkers are Driving GrowthBiomarkers will certainly change the way healthcare is provided. They are being increasingly used in early drug development and for clinical use as well, boosting their demand. The penetration of biomarkers in various therapeutic applications, the impact of market trends...

4 800 6 000 3 840
Jun 2014

Companion Diagnostics Market (2nd Edition), 2014-2024

233 pages • By Roots Analysis Private Ltd.

INTRODUCTIONWith an influx of new technologies and increasing awareness about personalized medicine, the pharmaceutical industry has steadily started to adopt a more customized drug development model. The concept of companion diagnostics holds huge potential for pharma companies as well as medical community. This new approach...

1 519 1 899 1 215
Jun 2014

Companion Diagnostics in Personalized Medicine and Cancer Therapy

292 pages • By TriMark Publications

Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic application and clinical outcome of a drug, such as with personalized medicine for oncology patients. The molecular diagnostics field plays...

2 720 3 400 2 176
Jun 2014

GLOBAL & USA CANCER BIOMARKER MARKET to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)

232 pages • By Kelly Scientific Publications

“GLOBAL & USA CANCER BIOMARKER MARKET to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-development, Business Strategies, Industry Trends, and Pipeline Analysis)” by Kelly Scientific Publications is a comprehensive report on the cancer biomarker industry and its impact on the health system....

2 720 3 400 2 176
May 2014

Biomarkers: Technologies and Global Markets

169 pages • By BCC Research

REPORT HIGHLIGHTSThe global biomarkers market is expected to grow from $29.3 billion in 2013 to $53.6 billion in 2018, a compound annual growth rate (CAGR) of 12.8%.This report provides:An overview of the global market for biomarkers.Analyses of global market trends, with data from 2012 and 2013, and...

5 320 6 650 4 256
Apr 2014

Mass Spectrometry for Clinical Applications: Market Analysis and End User Survey

250 pages • By Kalorama Information

For capacity, accuracy, and specificity of analysis, the use of mass spectrometry in clinical diagnostics and clinical research has grown dramatically in recent years. This Kalorama Information report, Mass Spectrometry for Clinical Applications: Market Analysis and End User Survey, looks at the growth of Mass Spec systems being used in diagnostics...

3 520 4 400 2 816
Apr 2014

Biomarker Technology Platforms for Cancer Diagnoses and Therapies

399 pages • By TriMark Publications

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis. In the major solid cancer types such as lung, breast, colon and prostate, long-term survival rates drop precipitously once metastatis has occurred....

2 720 3 400 2 176
Jan 2014

Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others) - Global Industry Analysis, Emerging Technologies, Competitive Intel

151 pages • By Allied Market Research

Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others) - Global Industry Analysis, Emerging Technologies, Competitive Intelligence, Growth Trends, Size, Share, Opportunities and Forecast, 2013 - 2020Biomarkers...

3 612 4 515 2 890
Dec 2013

Global Imaging Biomarkers Market 2014-2018

49 pages • By Infiniti Research Limited

TechNavio's analysts forecast the Global Imaging Biomarkers market to grow at a CAGR of 15.09 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Imaging Biomarkers market has also been witnessing the emergence of personalized medicines. However, the...

1 600 2 000 1 280
Nov 2013

Biomarkers: Discovery Techniques and Applications - A Global Market Overview

350 pages • By Industry Experts

The potential offered by biomarkers in shaping the outcomes of clinical trials, identifying new drug targets and developing diagnostic assays for detecting diseases early is immense, which has ensued in a large number of scientific publications coming out over the past two decades. Biomarker research encompasses widespread fields of discipline,...

3 600 4 500 2 880
Nov 2013

Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 201

327 pages • By MarketsandMarkets

Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 2018) A biomarker is an identifiable and measurable characteristic, which...

3 720 4 650 2 976
Sep 2013

Companion Biomarkers in Drug Development

356 pages • By TriMark Publications

Companion biomarkers are diagnostic tests that are specifically linked to a therapeutic drug either during its development or in the clinic. This linkage can be an important component of the drug development process; alternatively, the companion biomarker can be useful in ameliorating the regulatory process for the drug, or acting as an aid...

2 720 3 400 2 176
Aug 2013